Breaking Immune Tolerance to Generate Highly Potent Cross-Reactive Antibodies
This case study shows AlivaMab Biologics breaking immune tolerance to create antibodies against conserved targets.
This case study shows AlivaMab Biologics breaking immune tolerance to create antibodies against conserved targets.